Immix Biopharma Inc Announces Promising Results of NXC201 Therapy in Multiple Myeloma Study

Retrieved on: 2023-10-02 19:01:02

Tags for this article:

Click the tags to see associated articles and topics

Immix Biopharma Inc Announces Promising Results of NXC201 Therapy in Multiple Myeloma Study. View article details on hiswai: https://beststocks.com/immix-biopharma-inc-announces-promising-resul/

Excerpt

On October 2, 2023, Immix Biopharma Inc made an exciting announcement regarding the progress of their Phase 1b/2 NEXICART-1 study involving their.

Article found on: beststocks.com

View Original Article